(function(){var loadHandler=window['sl_{D0ADD9BC-5BCE-4B01-85F9-188A7AEC90E6}'];loadHandler&&loadHandler(148, '<div id="spr0_aef76ed"><div id="spr1_aef76ed" class="kern slide"><img id="img0_aef76ed" src="data/img2.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_aef76ed" class="kern slide"><div id="spr3_aef76ed" style="left:95.195px;top:158.347px;"><div style="width:0px;"><span id="txt0_aef76ed" data-width="186.011719" style="left:179.816px;top:0.564px;">up to 20% Early BC</span></div><div style="width:0px;"><span id="txt1_aef76ed" data-width="462.084961" style="left:45.041px;top:30.123px;">Progression on treatment in neo-adjuvant setting (pre-surgical)</span></div><div style="width:0px;"><span id="txt2_aef76ed" data-width="414.843750" style="left:68.596px;top:51.723px;">Relapses on treatment in adjuvant setting (after surgery)</span></div><div style="width:0px;"><span id="txt3_aef76ed" data-width="235.171875" style="left:157.961px;top:94.164px;">up to 90% Advanced BC</span></div><div style="width:0px;"><span id="txt4_aef76ed" data-width="339.943359" style="left:105.646px;top:123.723px;">Progression on treatment (inoperable disease)</span></div><div style="width:0px;"><span id="txt5_aef76ed" data-width="178.757813" style="left:185.916px;top:166.164px;">Primary (intrinsic)</span></div><div style="width:0px;"><span id="txt6_aef76ed" data-width="532.142578" style="left:9.861px;top:195.723px;">Progression or no response during neo-adjuvant treatment (pre-surgical)</span></div><div style="width:0px;"><span id="txt7_aef76ed" data-width="457.040039" style="left:47.561px;top:217.323px;">Relapse within 1-2 years on adjuvant treatment (after surgery)</span></div><div style="width:0px;"><span id="txt8_aef76ed" data-width="370.045898" style="left:90.506px;top:238.923px;">Progression within 2-6 months in advanced setting</span></div><div style="width:0px;"><span id="txt9_aef76ed" data-width="211.289063" style="left:169.681px;top:281.364px;">Secondary (acquired)</span></div><div style="width:0px;"><span id="txt10_aef76ed" data-width="263.540039" style="left:143.366px;top:310.923px;">After an evidence of initial response</span></div></div><div id="spr4_aef76ed" style="top:95.683px;"><div style="width:0px;"><span id="txt11_aef76ed" data-width="573.630859" style="left:74.355px;top:0.058px;">Relapse or progression on an endocrine treatment</span></div></div><div id="spr5_aef76ed" style="top:3.436px;"><div style="width:0px;"><span id="txt12_aef76ed" data-width="303.626953" style="left:95.019px;top:-0.954px;">Endocrine resistance</span></div></div></div></div>');})();